BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 78 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q4 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $195,033 | +78.5% | 38,468 | -1.1% | 0.01% | +25.0% |
Q4 2023 | $109,275 | +237.8% | 38,888 | +245.0% | 0.00% | +300.0% |
Q3 2023 | $32,351 | -2.0% | 11,272 | -5.3% | 0.00% | 0.0% |
Q1 2022 | $33,000 | -84.2% | 11,899 | -69.7% | 0.00% | -92.3% |
Q4 2021 | $209,000 | -18.4% | 39,300 | +86.9% | 0.01% | -48.0% |
Q2 2021 | $256,000 | – | 21,024 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEA Management Company, LLC | 3,449,845 | $104,289,000 | 4.42% |
Boxer Capital, LLC | 2,014,858 | $60,909,000 | 2.10% |
RA Capital Management | 2,589,904 | $78,293,000 | 1.43% |
Artal Group S.A. | 1,521,517 | $45,995,000 | 1.12% |
Ikarian Capital, LLC | 358,941 | $10,851,000 | 0.78% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 802,511 | $24,260,000 | 0.59% |
Bellevue Group AG | 1,403,000 | $42,413,000 | 0.59% |
Logos Global Management LP | 123,465 | $3,732,000 | 0.48% |
Casdin Capital, LLC | 289,395 | $8,748,000 | 0.39% |
HighVista Strategies LLC | 16,391 | $496,000 | 0.36% |